v3.24.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Cash flow from operating activities:    
Net loss $ (8,499) $ (11,495)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 145 198
Stock-based compensation expense 717 488
Issuance of common stock to vendor 55 391
Right-of-use asset amortization 263 264
Gain/(loss) on foreign currency transactions (1,120) 1,782
Transaction costs allocable to warrants 198  
Change in fair value of the warrant liability, net (465)  
Change in operating assets and liabilities:    
Accounts receivable (231) (32)
Research and development tax credit receivable 562 (213)
Prepaid expenses and other current assets 70 (42)
Accounts payable and accrued expenses 459 (385)
Lease liabilities (266) (265)
Income tax payable (23) 22
Other current liabilities 98 238
Net cash used in operating activities (8,037) (9,049)
Cash flows from investing activities:    
Purchases of property, plant and equipment (18) (79)
Net cash used by investing activities (18) (79)
Cash flow from financing activities:    
Proceeds from the issuance of preferred stock in private placement 12,386  
Proceeds from the issuance of warrants in private placement 1,763  
Proceeds from the issuance of common stock in private placement   2,000
Payment of issuance costs (1,483) (170)
Proceeds from the exercise of warrants 25  
Net cash provided by financing activities 12,691 1,830
Effect of exchange rate changes on cash (35) (693)
Net change in cash 4,601 (7,991)
Cash, beginning of period 4,235 12,226
Cash, end of period 8,836 4,235
Supplemental disclosure of cash and non-cash investing and financing activities    
Initial classification of fair value of warrants 1,837  
Right-of-use asset and lease liability additions $ 50 583
Issuance of common shares for consulting services   $ 633

Source

HTML PDF
ZIP